We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
Cap. Flow
-$14.8B
Cap. Flow %
-47.97%
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$92.3M
2
CLX icon
Clorox
CLX
+$90.2M
3
UHS icon
Universal Health Services
UHS
+$86.5M
4
AIG icon
American International
AIG
+$81.4M
5
CTVA icon
Corteva
CTVA
+$74.7M

Sector Composition

Rank Sector Weight
1 Technology 15.92%
2 Healthcare 14.54%
3 Financials 14.22%
4 Industrials 11.55%
5 Consumer Discretionary 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHOO icon
251
Steven Madden
SHOO
$3.18B
$41.8M 0.14%
1,230,346
-332,304
-21% -$10.9M
AOS icon
252
A.O. Smith
AOS
$8.61B
$41.8M 0.14%
885,517
+5,134
+0.6% +$252K
LPLA icon
253
LPL Financial
LPLA
$26.5B
$41.6M 0.14%
510,000
-8,100
-2% -$641K
THS
254
DELISTED
Treehouse Foods
THS
$41.5M 0.13%
766,873
-17,953
-2% -$1.05M
CMA
255
DELISTED
Comerica
CMA
$41.4M 0.13%
569,400
-8,900
-2% -$661K
MCK icon
256
McKesson
MCK
$99.5B
$41.3M 0.13%
+307,251
New +$38.3M
COR icon
257
Cencora
COR
$60.5B
$41.2M 0.13%
482,705
+238,005
+97% +$18.8M
CHRW icon
258
C.H. Robinson
CHRW
$20.6B
$40.6M 0.13%
481,500
-104,000
-18% -$8.75M
VRTX icon
259
Vertex Pharmaceuticals
VRTX
$122B
$40.6M 0.13%
221,413
-174,935
-44% -$30.6M
CPAY icon
260
Corpay
CPAY
$24.8B
$40.5M 0.13%
144,156
+30,608
+27% +$8.01M
XRX icon
261
Xerox
XRX
$357M
$40.4M 0.13%
1,140,500
-17,500
-2% -$584K
EPAM icon
262
EPAM Systems
EPAM
$4.92B
$40.3M 0.13%
232,713
-142,062
-38% -$24.5M
NVEE
263
DELISTED
NV5 Global
NVEE
$40.2M 0.13%
1,975,488
+116,596
+6% +$2.08M
CRM icon
264
Salesforce
CRM
$142B
$39.5M 0.13%
260,114
-147,875
-36% -$23.2M
ESTC icon
265
Elastic
ESTC
$6.37B
$39.3M 0.13%
526,478
-2,473
-0.5% -$202K
WBS icon
266
Webster Financial
WBS
$12.5B
$39.3M 0.13%
822,765
-64,835
-7% -$3.23M
TXN icon
267
Texas Instruments
TXN
$255B
$39.3M 0.13%
342,391
-122,516
-26% -$13.7M
MRTX
268
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$38.8M 0.13%
376,691
-253,693
-40% -$19.8M
IPHI
269
DELISTED
INPHI CORPORATION
IPHI
$38.6M 0.13%
770,458
+146,831
+24% +$6.84M
COST icon
270
Costco
COST
$422B
$38.6M 0.13%
145,900
+3,200
+2% +$798K
SPGI icon
271
S&P Global
SPGI
$130B
$38.5M 0.13%
169,200
-21,200
-11% -$4.63M
POLY
272
DELISTED
Plantronics, Inc.
POLY
$38.5M 0.13%
1,040,536
-65,329
-6% -$3.03M
APPN icon
273
Appian
APPN
$1.88B
$38.2M 0.12%
1,059,985
+129,625
+14% +$4.44M
SPOT icon
274
Spotify
SPOT
$102B
$38.1M 0.12%
+260,542
New +$35.8M
WHD icon
275
Cactus
WHD
$3.74B
$38M 0.12%
1,148,273
+414,140
+56% +$14.4M

Similar funds

Lord, Abbett & Co's Q2 2019 Portfolio in Review

As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.

  • Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
  • Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
  • Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
  • Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
  • Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
  • Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
  • Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.

Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.